Vice President
Certara
Dr. Mark Sale MD has more than thirty years in population pharmacokinetic/ pharmacodynamics modeling in both academics and industry. In his current role as Vice President at Certara he is responsible for conducting and overseeing population pharmacokinetic/pharmacodynamic analyses and strategic consulting on drug development. Dr. Sale also contributes to the software development group at Certara, supporting development of artificial intelligence and machine learning systems in pharmacometrics.
Prior to this role, Dr. Sale was global director of Modeling and Simulation at GlaxoSmithKline and assistant professor of Medicine and Pharmacology at Georgetown, respectively. He also has faculty appointments at Indiana University School of Medicine and Mercer University School of Pharmacy and State University of New York at Buffalo.
Dr. Mark Sale completed his medical training at the Ohio State University, residency training in internal medicine at Indiana University and a fellowship in Clinical Pharmacology at Stanford.
Disclosure(s): No financial relationships to disclose
When AI Meets Drug Development
Friday, March 29, 2024
3:00 PM – 4:00 PM MDT